Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Viral (RSV) Infection”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Not applicableStudy completedNCT05572658
What this trial is testing

Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 10,994
Not applicableEnded earlyNCT05105191
What this trial is testing

Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room

Who this might be right for
Influenza Viral InfectionsRSV Infection
Erasme University Hospital 280
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Not applicableStudy completedNCT02622009
What this trial is testing

Viral Infections in BAL and Bronchial Biopsies of Stable COPD Patients

Who this might be right for
HRV and RSV Presence in the Lungs of Stable COPD Patients.
University of Athens 53
Testing effectiveness (Phase 2)Study completedNCT02718937
What this trial is testing

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Biota Pharma Europe Limited 60
Not applicableStudy completedNCT05268939
What this trial is testing

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19

Who this might be right for
COVID-19Influenza AInfluenza Type B+1 more
LumiraDx UK Limited 668
Not applicableActive Not RecruitingNCT06077968
What this trial is testing

Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease

Who this might be right for
Respiratory Syncytial Viruses
Pfizer 1
Post-approval studies (Phase 4)Study completedNCT02571517
What this trial is testing

Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis

Who this might be right for
Bronchiolitis, Viral
Fundació Sant Joan de Déu 94
Large-scale testing (Phase 3)Active Not RecruitingNCT07117487
What this trial is testing

MRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 507
Not applicableUnknownNCT05277298
What this trial is testing

Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa

Who this might be right for
SARS-CoV-2 InfectionInfluenzaRespiratory Syncytial Virus (RSV)
National Institute for Communicable Diseases, South Africa 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT06999603
What this trial is testing

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Who this might be right for
Viral Pneumonia
Synairgen Research Ltd. 550
Early research (Phase 1)Study completedNCT00345670
What this trial is testing

Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children

Who this might be right for
Healthy
MedImmune LLC 120
Large-scale testing (Phase 3)Study completedNCT06060457
What this trial is testing

Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,900
Early research (Phase 1)Study completedNCT01230645
What this trial is testing

RV568 - Viral Challenge With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Respivert Ltd 42
Not applicableUnknownNCT05946538
What this trial is testing

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Who this might be right for
Respiratory Viral Infection
AusDiagnostics Pty Ltd. 1,000
Early research (Phase 1)Study completedNCT02484417
What this trial is testing

Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers

Who this might be right for
Upper Respiratory Tract Infection
National Institute of Allergy and Infectious Diseases (NIAID) 32
Not applicableStudy completedNCT05794412
What this trial is testing

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study

Who this might be right for
SARS-CoV-2 InfectionInfluenza Viral InfectionsVirus Shedding+2 more
University Hospital, Geneva 320
Not applicableWithdrawnNCT01098227
What this trial is testing

Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections

Who this might be right for
BronchiolitisInfectionNitric Oxide
NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT03715023
What this trial is testing

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 5
Testing effectiveness (Phase 2)Study completedNCT03303625
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Infections
Janssen Vaccines & Prevention B.V. 48
Load More Results